CYOA App Intervention for Social Media Use in Adolescents With Depression
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07936890. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Choose Your Own Adventure: A Novel Intervention to Regulate Social Media Use in Adolescents With Depression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will develop and test Choose Your Own Adventure, a personalized app-based intervention designed to help adolescents with depression regulate social media use. Adolescents ages 13 to 17 years with major depressive disorder and daily TikTok use will be randomized to either the CYOA app intervention or no intervention. The CYOA app is designed to detect individualized patterns of problematic social media use and offer personalized options to disrupt "runaway train" social media use. The study will assess feasibility, acceptability, preliminary effects on social media use and mood, and potential mechanisms including social media self-control failure. Participants will complete baseline, post-intervention, and 3-month follow-up assessments.
Study identification
- NCT ID
- NCT07936890
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 13 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2027 (Estimated)
- Primary completion
- Oct 10, 2029 (Estimated)
- Completion
- Oct 10, 2030 (Estimated)
- Last update posted
- Nov 13, 2026
2027 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Minnesota Masonic Institute for the Developing Brain | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07936890, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.